2023 ISAKOS Biennial Congress ePoster
Effects of Focused Extracorporeal Shock Wave Therapy in Reducing Pain In Patients With Anterior Knee Pain After ACLR with BTB Autograft
Hideaki Fukuda, MD, Tokyo, TOKYO JAPAN
FUNABASHI ORTHOPEDIC HOSPITAL, FUNABASHI CHIBA, CHIBA, JAPAN
FDA Status Not Applicable
Summary
ESWT treatment significantly reduces prevalence and severity of anterior knee pain after ACLR using BTB autograft.
ePosters will be available shortly before Congress
Abstract
?Purpose?Anterior knee pain (AKP) is not uncommon occurrences following ACL reconstructions (ACLR) using bone patellar tendon–bone autograft (BTB). The aim of this study was to assess the effect of a focused extracorporeal shock wave therapy (ESWT) in the treatment of AKP after ACLR using BTB.
?Material and Methods?Between 2015 and 2020, a total of 120 consecutive patients underwent primary ACLR using BTB autograft performed by single surgeon. Forty patients (33%) who had AKP after surgery were followed prospectively, and they were randomly divided into either ESWT group (n = 20) or non-ESWT group (n =20).
Reported anterior knee pain, numerical rating scale (NRS) score, complications, and patient reported outcome measures, such as Lysholm score and KOOS, were compared between groups. All patients were evaluated 24 months after surgery.
?RESULT? ESWT group had less anterior knee pain at last clinic follow up (10.0% vs. 60.0% p?=?0.002) as well as lower NRS anterior knee pain scores (1.08 vs. 3.74, p?=?0.004). There were no complications in either group. No differences were found in the LYSHOLM score and KOOS.
?Conclusion? ESWT treatment significantly reduces prevalence and severity of anterior knee pain after ACLR using BTB autograft. Larger randomized trials are needed to confirm the benefits of ESWT.